echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Pharmaceutical market pattern changes, pharmaceutical equipment industry meets more opportunities and challenges

    Pharmaceutical market pattern changes, pharmaceutical equipment industry meets more opportunities and challenges

    • Last Update: 2019-08-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network market analysis] with the deepening of medical reform, the promotion of consistency evaluation, the intensive introduction of policies such as "4 + 7" volume procurement and fee control upgrading, the pattern of China's pharmaceutical market has changed The industry believes that cheap, high-quality generic drugs and innovative drugs with value will have more advantages in the market According to the market proportion, generic drugs account for about 90% of the drug market With the continuous improvement of industry concentration, the integration and upgrading of excellent generic pharmaceutical enterprises will be forced In this context, it will also bring more opportunities and challenges to the pharmaceutical equipment industry In fact, in terms of policy, in April 2018, China issued the opinions on reforming and improving the supply guarantee and use policy of generic drugs, aiming to encourage the research and development of generic drugs, improve the quality and efficacy of generic drugs, and promote the development of China from a big pharmaceutical country to a powerful pharmaceutical country In terms of improving the quality and efficacy of generic drugs, it is pointed out that the manufacturing level will be improved The specific performance is as follows: vigorously improve the level of pharmaceutical equipment and intelligent manufacturing, improve the research and manufacturing capacity and equipment performance of key equipment, promote the application of new technology, optimize and improve process production management, strengthen overall quality control, improve the level of key process control, and promote the solution of bottleneck problems restricting product quality Starting from the introduction of national policies, local governments also have targeted measures For example, on December 20, 2018, Inner Mongolia Autonomous Region issued a notice on printing and distributing the work plan for reforming and improving the supply guarantee and use policy of generic drugs It is emphasized that the level of pharmaceutical equipment and intelligent manufacturing should be greatly improved, the research and manufacturing capacity and equipment performance of key equipment should be improved, new technology should be popularized and applied, process production management should be optimized and improved, overall quality control should be strengthened, control level of key process should be improved, and bottleneck problems restricting product quality should be solved It can be seen that improving the level of pharmaceutical equipment and intelligent manufacturing has become an important factor in improving the quality and efficacy of generic drugs In the era of intelligent manufacturing, the pharmaceutical equipment industry also actively understands, explores and applies it Large leading pharmaceutical equipment enterprises in China, such as truking, Dongfu long, and Weilong technology, have long smelled the future They started layout in terms of intelligent pharmaceutical equipment, actively explored pharmaceutical equipment 4.0, developed pharmaceutical equipment with Chinese characteristics, and gradually pushed their products to the international market   However, most of the pharmaceutical equipment enterprises in China are small and medium-sized, and the overall strength is still very different from that of foreign pharmaceutical equipment With the increasingly fierce market competition in the pharmaceutical equipment industry, as well as the rise in labor costs and material costs, the level of Intelligent Manufacturing in the pharmaceutical equipment industry still needs to rely on more policy support to encourage these enterprises to increase research and development We should actively invest in innovation and strive to open up a larger market According to the industry, in addition to generic drugs, the demand for small pharmaceutical equipment will continue to expand with the development environment of domestic innovative drugs becoming better At present, many pharmaceutical equipment enterprises can provide specialized small-scale pharmaceutical equipment according to the needs of users, and also enterprises seize the current opportunity to continuously improve the equipment structure Compared with the production-oriented pharmaceutical equipment, the requirements of small-scale pharmaceutical equipment are higher, even more precise than the production-oriented equipment Therefore, for enterprises trying to develop small-scale pharmaceutical equipment, they need to overcome greater difficulties.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.